The purpose of this legislation is to streamline the process for certain drugs, biological products, and medical devices to gain marketing approval in the United States if they are already authorized for sale in other countries. This is intended to make lifesaving treatments more accessible to American patients by reducing the time and complexity involved in getting these products approved for use in the U.S. Key provisions of the legislation include a process for granting reciprocal marketing approval.